Recently, Valiant Pharmaceutical’s first active pharmaceutical ingredient (API), olmesartan medoxomil, successfully passed the rigorous review of the European Directorate for the Quality of Medicines and HealthCare (EDQM) and obtained the Certificate of Suitability to the European Pharmacopoeia (CEP), supported by its advanced and independently developed research and production process.
On March 12, Liao Jiasheng, Chairman of CECEP, met with Zeng Yuqun, Chairman and CEO of CATL, and his delegation at CECEP headquarters.
Recently, the Ministry of Industry and Information Technology concluded the public review of the latest list of national-level green manufacturing entities.
On September 30, CECEP Wind-power successfully connected its first wind turbine equipped with a 100% domestically developed PLC controller and main control system to the grid at Lvnaobao Wind Farm.
Recently, the high-altitude ultra-high-voltage (UHV) test hall project in Xizang, for which CQEC’s Industrial Institute was responsible for the feasibility study and construction design, was officially put into operation.
On October 10, Liao Jiasheng, Chairman of CECEP, met with Wangdui, Vice Chairman and General Manager of Xizang State-Owned Capital Investment and Operation Co., Ltd., at CECEP headquarters.
Recently, the first hospital outpatient facility in China built using a Modular Integrated Construction (MIC) system, designed by the Shenzhen Machinery Institute Architectural Design under CQEC, was officially completed and put into operation at the original site of Shenzhen Longhua District Central Hospital.
Recently, CECEP Solar stood out among 58 participating companies in the 2025 Chongqing ESG Pioneer Enterprise Selection campaign and was named a Chongqing ESG Pioneer Enterprise.
第  34  /  52  页  总条数: 258
Produced By CMS 网站群内容管理系统 publishdate:2026-09-18 11:58:17